Research questions concerning prostate cancer screening

Cancer Causes and Control

Volumn 8, Issue 4, 1997, Pages 668-671

  Collins, Mary McNaughton ^a   Fletcher, Robert H ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; CASE CONTROL STUDY; COHORT ANALYSIS; CONFERENCE PAPER; MEDICAL RESEARCH; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; SCREENING TEST; THORAX RADIOGRAPHY;

COST-BENEFIT ANALYSIS; HUMANS; MALE; MASS SCREENING; PATIENT SELECTION; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RESEARCH;

EID: 0030797259     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018410817024     Document Type: Conference Paper

References (18)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5-27.
2. Woolf SH. Current concepts: Screening for prostate cancer with prostate-specific antigen - an examination of the evidence. N Engl J Med 1995; 333: 1401-5.
3. Prorok P. The National Cancer Institute Multi-Screening Trial. Can J Oncol 1994; 4(Suppl): 98-101.
4. Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal, and ovarian screening trial of the National Cancer Institute. J Urol 1994; 152: 1905-9.
5. Schroder FH. The European Screening Study for Prostate Cancer. Can J Oncol 1994; 4(Suppl): 102-5.
6. Gann PH, Hennekens CH, Stampfer MF. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 1995; 25: 289-94.
7. Richie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993; 42: 365-74.
8. Fowler PJ, Barry MJ, Lu-Yao G, et al. Patient-reported complications and follow-up treatment after radical prostatectomy. Urology 1993; 42: 622-9.
9. Lu-Yao GL, Potosky AL, Albertsen PC, et al. Follow-up prostate cancer treatments after radical prostatectomy: a population based study. JNCI 1996; 88: 166-73.
10. Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 1994; 152: 1910-4.
11. Stephenson J. Prostate cancer gene hunters track their quarry. [Medical News and Perspectives]. JAMA 1996; 276: 861-2.
12. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-7.
13. Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 1991; 337: 1526-9.
14. Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer 1974; 34: 2018-27.
15. Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271: 1011-3.
16. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109: 1781-90.
17. Bhattacharya I, Sack E. Screening colonoscopy: the cost of common sense. Lancet 1996; 347: 1744-5.
18. McNaughton Collins M, Barry MJ. Controversies in prostate cancer screening: Analogies to the early lung cancer screening debate. JAMA 1996; 276: 1976-9.